Our Experts in the News
-
Investigation spotlights rise of for-profit ethics boards in research
February 16, 2023
The Washington Post
-
Novo Nordisk apologises for not disclosing sponsorship of anti-obesity training
February 12, 2023
Financial Times
-
Public Health Groups Doubt FDA’s ACNU Proposal Will Expand OTC Access, Benefit Public Health
January 17, 2023
HBW Insight
-
What a congressional investigation reveals about FDA's approval of Aduhelm
January 4, 2023
Advisory Board
-
House investigation faults FDA, Biogen for Alzheimer’s drug approval
December 29, 2022
The Washington Post
-
Gabapentin
December 4, 2022
Full Measure
-
Discipline for addicted physicians who relapse is often lenient, secretive
November 28, 2022
Investigate TV
-
Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Says
November 2, 2022
MedPage Today
-
Private Practice: Confidential drug and alcohol programs for physicians keep patients in the dark
October 31, 2022
Hawaii News Now
-
Speedy FDA approvals in focus as agency weighs withdrawal of preterm birth drug
October 21, 2022
BioPharma Dive
-
FDA Wants Pregnancy Drug Off the Market
October 18, 2022
NBC Nightly News
-
Dueling announcements: As Biden touts cuts for Medicare Part B, study about a new Alzheimer's drug shows promise
September 28, 2022
Fierce Healthcare
-
Who's the Real Boss at the FDA?
September 21, 2022
The American Conservative
-
Amazon Ending Its Virtual Health Service Amazon Care: What This Means
September 8, 2022
Healthline
-
Desperate patients want a new ALS drug. The FDA is not sure it works.
September 6, 2022
The Washington Post
-
How King County’s efforts to help at-risk students created a record that could jeopardize their privacy
August 14, 2022
The Seattle Times
-
State Sen. Gustavo Rivera faces criticism on stalled N.Y. efforts to regulate gabapentin, an opioid enhancer drug
August 6, 2022
New York Daily News
-
An FDA official bolting to Big Tobacco shines a light on the agency’s revolving-door problem
August 3, 2022
Grid
-
F.D.A. Tobacco Science Official Takes Job at Philip Morris
July 27, 2022
The New York Times
-
Proposed legislation takes aim at prescription drug advertising
July 11, 2022
Regulatory Focus
Login
Subscribe